Research Article
Study the Mechanism of Gualou Niubang Decoction in Treating Plasma Cell Mastitis Based on Network Pharmacology and Molecular Docking
Table 4
Basic information of the top 15 pathways with the most target genes.
| ID | Term | Count | value | Input |
| hsa05200 | Pathways in cancer | 22 | | BCL2L1/ERBB2/EGFR/HIF1A/RB1/MAPK1/MYC/IGF2/TCF7/CDKN2A/FOS/PPARG/VEGFA/CASP3/ESR1/CXCL8/CASP9/IL6/MMP9/MMP1/MMP2/BCL2 | hsa05219 | Bladder cancer | 11 | | ERBB2/CDKN2A/CXCL8/EGFR/RB1/MAPK1/VEGFA/MMP9/MYC/MMP2/MMP1 | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 12 | | NOS3/CASP3/CXCL8/IL6/MAPK1/VEGFA/VCAM1/ICAM1/SELE/COL3A1/MMP2/BCL2 | hsa05161 | Hepatitis B | 12 | | PCNA/TLR2/CASP3/FOS/CXCL8/RB1/CASP9/IL6/MAPK1/MMP9/MYC/BCL2 | hsa04151 | PI3K-Akt signaling pathway | 14 | | IGF2/BCL2L1/NOS3/ERBB2/EGFR/CASP9/IL6/INSR/MAPK1/VEGFA/MCL1/TLR2/MYC/BCL2 | hsa05205 | Proteoglycans in cancer | 12 | | IGF2/ERBB2/CASP3/ESR1/EGFR/HIF1A/TLR2/MAPK1/VEGFA/MMP9/MYC/MMP2 | hsa01522 | Endocrine resistance | 10 | | ERBB2/CDKN2A/ESR1/FOS/EGFR/RB1/MAPK1/MMP9/MMP2/BCL2 | hsa04066 | HIF-1 signaling pathway | 10 | | ERBB2/NOS3/TIMP1/EGFR/HIF1A/IL6/INSR/MAPK1/VEGFA/BCL2 | hsa04668 | TNF signaling pathway | 10 | | IRF1/CASP3/FOS/SELE/IL6/MAPK1/VCAM1/ICAM1/MMP9/MMP3 | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 11 | | CASP3/FOS/CXCL8/HIF1A/CASP9/IL6/MAPK1/VEGFA/RB1/ICAM1/MYC | hsa04915 | Estrogen signaling pathway | 10 | | NOS3/FOS/EGFR/ESR1/CTSD/MAPK1/PGR/MMP9/MMP2/BCL2 | hsa05206 | MicroRNAs in cancer | 12 | | ERBB2/TP63/CDKN2A/CASP3/CDC25C/EGFR/MAPK1/VEGFA/MCL1/MMP9/MYC/BCL2 | hsa05215 | Prostate cancer | 9 | | ERBB2/TCF7/EGFR/RB1/CASP9/MAPK1/MMP9/MMP3/BCL2 | hsa05212 | Pancreatic cancer | 8 | | BCL2L1/ERBB2/CDKN2A/EGFR/RB1/CASP9/MAPK1/VEGFA | hsa04926 | Relaxin signaling pathway | 9 | | NOS3/FOS/EGFR/MAPK1/VEGFA/MMP9/COL3A1/MMP2/MMP1 |
|
|